The FDA approved Teal Health's Teal Wand, the first at-home cervical cancer screening test. This vaginal swab test detects HPV, the leading cause of cervical cancer, offering a less invasive alternative to traditional pelvic exams. Increased access to screening is expected, particularly for women in rural areas with limited healthcare access. While the test requires an initial telehealth consultation and positive results necessitate further in-office testing, insurance coverage is anticipated due to U.S. Preventive Services Task Force endorsement. Experts remain interested in the cost and patient follow-up rates.

Prepared by Olivia Bennett and reviewed by editorial team.